Brian Szabo, DO
Ophthalmology · Tampa, FLNPI 1174056741
Payments from drug & device makers
Across 132 payments — averaging $654.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Rxsight Inc$61K
- Johnson & Johnson Surgical Vision, Inc.$21K
- Glaukos Corporation$2K
- Alcon$416
- Sight Sciences, Inc.$275
- Amgen$208
- plus $907 from 13 others
What the payments were for
- Consulting fees$66,77277%
- Speaking & faculty fees$260%
- Grants$15,00017%
- Travel & lodging$3390%
- Food & beverage$4,2745%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Rxsight Inc | 24 | $61,457 |
| Johnson & Johnson Surgical Vision, Inc. | 33 | $21,358 |
| Glaukos Corporation | 10 | $1,789 |
| Alcon | 11 | $416 |
| Sight Sciences, Inc. | 7 | $275 |
| Amgen(2 entities) | 10 | $208 |
| AbbVie | 9 | $156 |
| Sun Pharmaceutical Industries Inc. | 5 | $122 |
| Johnson & Johnson Vision Care, Inc. | 1 | $103 |
| Bausch & Lomb Americas Inc. | 4 | $100 |
| Genentech USA, Inc. | 4 | $94 |
| Biotissue Holdings Inc. | 3 | $78 |
| Mallinckrodt Hospital Products Inc. | 3 | $67 |
| Tarsus Pharmaceuticals, Inc. | 2 | $51 |
| Ocular Therapeutix, Inc. | 2 | $45 |
| Dompe US, Inc. | 1 | $30 |
| Harrow Eye, LLC | 1 | $24 |
| Kala Pharmaceuticals, Inc. | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$61,164
- RXSIGHT INJECTOR CARTRIDGE$61,164
- RXSIGHT INJECTOR HANDPIECE$61,164
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$61,164
- LIGHT ADJUSTABLE LENS (LAL)$61,051
- Tecnis IOL$20,862
- Compact Intuitiv$19,822
- Travoprost Intraocular Implant - iDose$1,400
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$210
- KXL System$210
- iDoseTR$210
- Photrexa Viscous and Photrexa$210
- Clareon$141
- ARGOS$141
- Hydrus Microstent$141
- OMNI(R) SURGICAL SYSTEM (US)$123
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$113
- Tecnis Simplicity$104
- Acuvue$103
How this compares
$86,411 in reported general payments places this provider in the 90th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProlensaBromfenac Sodium | 110 | $38,713 |
| LumiganBimatoprost | 41 | $23,064 |
| Prednisolone Acetate | 577 | $20,107 |
| Bromfenac Sodium | 83 | $15,565 |
| IlevroNepafenac | 41 | $15,082 |
| RhopressaNetarsudil Mesylate | 24 | $10,557 |
| Ketorolac Tromethamine | 306 | $7,437 |
| MoxifloxacinMoxifloxacin Hcl | 336 | $7,423 |
| Difluprednate | 78 | $7,399 |
| Alphagan PBrimonidine Tartrate | 12 | $6,283 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 17 | $5,536 |
| Latanoprost | 483 | $5,184 |
| Brimonidine Tartrate | 153 | $4,981 |
| Ofloxacin | 350 | $4,018 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 145 | $2,351 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Alphagan P | $156 | $29,34853 claims |
| AlconSimbrinza | $416 | $5,53617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,405 ophthalmology providers in Florida.
Other ophthalmology in Tampa
- Ivan SunerTampa$3.7M
- Pedram HamrahTampa$2.2M
- Thomas NewsomTampa$1.5M
- Courtney BoveeTampa$884K
- Ashley CraneTampa$491K
- Don PerezTampa$367K
- David EichenbaumSt Petersburg$34.4M
- Robert RadenDelray Beach$7.8M
- Carl DanzigPompano Beach$5.3M
- Bruce SegalDelray Beach$4.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.